FindTrial
Sign In

Bi-level positive airway pressure (BiPAP) VS nasal continuous positive airway pressure (NCPAP) as the initial mode of treatment of twin premature infants with respiratory distress syndrome (RDS)

Bi-level positive airway pressure (BiPAP) VS nasal continuous positive airway pressure (NCPAP) as the initial mode of treatment of twin premature infants with respiratory distress syndrome (RDS)

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100045680
Enrollment
Unknown
Registered
2021-04-23
Start date
2018-03-01
Completion date
Unknown
Last updated
2021-12-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neonatal respiratory distress syndrome

Interventions

BiPAP group:Bi-level positive airway pressure
BiPAP group: nasal continuous positive airway pressure

Sponsors

Qujing Maternal and Child Health Hospital Nanyuan New District
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. The gestational age is 26 to 37 weeks; 2. The clinical diagnosis is proposed to be RDS (combined with clinical symptoms and chest X-ray findings).

Exclusion criteria

Exclusion criteria: 1. Respiratory system malformations (micrognathia syndrome, posterior nostril atresia, etc.), complex congenital diseases; 2. Severe circulatory function instability or cardiac arrest or pulmonary hemorrhage requires mechanical ventilation; 3. Automatic discharge during treatment after admission.

Design outcomes

Primary

MeasureTime frame
Non-invasive respiratory support success rate;—

Countries

China

Contacts

Public ContactLi Chuanfeng

Qujing Maternal and Child Health Hospital Nanyuan New District

1060318663@qq.com+86 13988970311

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026